ProCAID

Trial description
An open label phase I/randomised, double-blind phase II study in metastatic castration resistant Prostate Cancer of AZD5363 in combination with Docetaxel and prednisolone chemotherapy
Contact name
Dr Danish Mazhar
Trial start date
Tuesday, November 14, 2017
Trial end date
Thursday, October 31, 2019
Trial tumour type
Prostate
Show on Radiotherapy
No